|
Jun 24
|
Eli Lilly seeks to expand Zepbound use to treat sleep apnea
|
|
Jun 24
|
Best Momentum Stock to Buy for June 24th
|
|
Jun 24
|
Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes
|
|
Jun 24
|
ResMed Inc. (NYSE:RMD) Shares Could Be 24% Below Their Intrinsic Value Estimate
|
|
Jun 21
|
IDEXX (IDXX) Business Faces Macroeconomic Woes, FX Headwinds
|
|
Jun 21
|
Quest Diagnostics (DGX) Gains From New M&As Amid Competition
|
|
Jun 21
|
Zacks Industry Outlook Highlights Boston Scientific, ResMed, Lantheus and Haemonetics
|
|
Jun 20
|
Thermo Fisher's (TMO) New Buyouts Aid Growth, FX Issues Stay
|
|
Jun 19
|
Boston Scientific (BSX) to Buy Silk Road, Boost Cardiology
|
|
Jun 19
|
QIAGEN's (QGEN) New QCI Interpret Release Enhances AI Functions
|
|
Jun 11
|
Zacks.com featured highlights include ResMed, Booz Allen Hamilton, CrediCorp and American Express
|
|
Jun 10
|
Align Technology (ALGN) Gains From New Alliances, Global Growth
|
|
Jun 10
|
4 GARP Stocks to Scoop up for Maximum Returns
|
|
Jun 10
|
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
|
|
Jun 10
|
Here's Why Omnicell (OMCL) Should be in Your Portfolio Now
|
|
Jun 7
|
Under The Bonnet, ResMed's (NYSE:RMD) Returns Look Impressive
|
|
Jun 6
|
Here's Why ResMed (RMD) is a Strong Momentum Stock
|
|
Jun 4
|
HealthEquity (HQY) Q1 Earnings Surpass Estimates, Margins Up
|
|
May 23
|
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
|
|
May 23
|
Here's How Much a $1000 Investment in ResMed Made 10 Years Ago Would Be Worth Today
|